A detailed history of Versant Venture Management, LLC transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 506,821 shares of ADVM stock, worth $3.99 Million. This represents 7.72% of its overall portfolio holdings.

Number of Shares
506,821
Previous 506,822 -0.0%
Holding current value
$3.99 Million
Previous $7.17 Million 51.49%
% of portfolio
7.72%
Previous 9.99%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$6.56 - $13.89 $6 - $13
-1 Reduced -0.0%
506,821 $3.48 Million
Q1 2024

May 03, 2024

SELL
$0.8 - $16.06 $3.65 Million - $73.3 Million
-4,561,411 Reduced 90.0%
506,822 $7.17 Million
Q1 2021

May 07, 2021

BUY
$9.26 - $14.36 $595,797 - $923,936
64,341 Added 1.29%
5,068,233 $50 Million
Q4 2020

Feb 16, 2021

SELL
$9.84 - $14.26 $19.7 Million - $28.5 Million
-2,000,000 Reduced 28.56%
5,003,892 $54.2 Million
Q2 2020

Jul 20, 2020

SELL
$8.53 - $25.64 $548,828 - $1.65 Million
-64,341 Reduced 0.91%
7,003,892 $146 Billion
Q1 2020

Apr 28, 2020

BUY
$7.98 - $16.32 $56.4 Million - $115 Million
7,068,233 New
7,068,233 $69.1 Billion

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $783M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.